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This study demonstrates the induction of lysozyme mRNA expression in situ in tissue macrophages 
(MR) of mice following in vivo stimulation. The resting resident  tissue MR of most tissues 
do not contain enough lysozyme mRNA to be detected by in situ hybridization using 3sS-labeled 
RNA probes. Following Bacille Calmette Guerin or Plasmodium  yoelli infection,  however, MR 
recruited to liver and spleen hybridize strongly to the lysozyme probe. Within 24 h of infection, 
cells found in the marginal zone of the spleen begin to produce lysozyme mRNA. This response 
is also evoked by a noninfectious agent (intravenously injected sheep erythrocytes), and is possibly 
the result of an early phagocytic interaction.  Later in the infection,  other cells in the red and 
white pulp of the spleen, and cells in granulomas in the liver, become lysozyme-positive. Kupffer 
cells are rarely lysozyme-positive. Lysozyme mKNA levels in liver granulomas remain relatively 
constant during the infection, and lysozyme is produced by most granuloma cells. This contrasts 
with tumor necrosis factor ol (TNFot) mRNA, which is produced by fewer cells in the granuloma, 
and which can be massively induced by lipopolysaccharide administration.  The production of 
lysozyme, previously considered a constitutive function of MR, is therefore an indicator of MR 
activation in vivo, where immunologically specific and nonspedfic stimuli both stimulate lysozyme 
production at high levels in subpopulations  of cells occupying discrete anatomical locations. 
M 
acrophages (M~) 1 in tissue culture are an important 
source of physiologically important secretory products 
such as cytokines, growth factors, complement and clotting 
proteins, proteases and other enzymes (1). There is, however, 
little information on their actual secretory function in vivo. 
Studies based solely on the intracellular localization of pro- 
teins in tissue sections may be misleading, because MR do 
not store large amounts of protein before exocytosis, and 
secreted proteins may also be found in actively endocytic cells 
without having been synthesized there (2, 3). The availability 
of nucleic acid probes for various MR products now allows 
specific mKNA species to be localized in situ, giving an in- 
dication of biosynthetic activity in vivo. 
Lysozyme is an abundant protein product of myelomono- 
cytic cells and is generally regarded as the prototypical con- 
stitutive  marker of MR biosynthetic activity (2). The con- 
stitutive and uniform production of lysozyme by unstimulated 
and stimulated MR in vitro contrasts with that of most other 
~ Abbreviations  used  in  this paper:  BCG, Bacille Calmette  Guefin; Mq~, 
macrophage(s); PPD, purified protein derivative. 
MR secretory proteins, whose synthesis and secretion are regu- 
lated by inflammatory stimuli (1). Resident tissue MR, how- 
ever, are heterogeneous  in their production of lysozyme in 
vivo; for instance, while lamina propria MR in the small in- 
testine are lysozyme-negative,  alveolar  MR are strongly positive 
(4). In addition, in granulomatous disorders such as sarcoid- 
osis, or in monocytic leukaemias, where the number of MR 
in the body is increased, serum and urine lysozyme levels are 
raised, and may be used as indicators of disease activity (5). 
These observations suggest that while lysozyme production 
in vitro may be constitutive,  lysozyme production in vivo 
is regulated. The human and mouse lysozyme cDNA's have 
recently been cloned and sequenced, and shown to crosshybri- 
dize readily (4, 6). We have therefore used radio-labeUed  KNA 
probes of high specific activity to localize the production of 
lysozyme mRNA in murine tissues. 
BaciUe Calmette Guerin (BCG) infection produces a chronic 
granulomatous disease in which large numbers of MR are 
recruited to the liver, spleen and lungs,  and we have exam- 
ined the regulation of lysozyme mRNA levels in Mq~ in 
normal and BCG infected mice, as well as in mice treated 
with other stimuli (7, 8). TNF has been implicated in the 
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therefore compared the patterns of lysozyme and TNF mRNA 
distribution in infected tissues. The results of these studies 
show that lysozyme production in the resident  tissue M~ 
of the liver and spleen is not constitutive, and that a variety 
of stimuli can induce lysozyme production in subpopulations 
of M~.  At the same time the regulation of lysozyme syn- 
thesis could be distinguished from that of the prototypical 
inflammatory marker TNF. 
Materials  and Methods 
Mice.  C57/B16 and Balb/c mice were bred and housed in the 
Sir William Dunn School of Pathology. Athymic nude C57/B16 
mice and euthymic littermates were obtained from Harlan/Olac 
(Bicester,  UK). 
Bacille Calmette Guerin (BCG) Infection.  Stocks of frozen BCG 
organisms (I>90%  viable) were obtained from the Pasteur Insti- 
tute (Paris, France). Mice were injected intravenously with  +  107 
viable organisms each in 500 #1 of sterile  PBS. To obtain lymph 
node cells sensitized  to BCG, mice were injected with  _+  107 or- 
ganisms in 50 #1 into each hind footpad, and the draining lymph 
nodes (popliteal,  inguinal, and para-aortic) collected 7 d later. LPS 
challenge was performed by injection of 25 #g of Escherichia coli 
LPS (Sigma Chemical Co., St. Louis, MO) in 100 #1 of saline into 
the peritoneal cavity of infected mice. The mice were killed 2 h later. 
Adoptive  Transfer.  Single cell suspensions  were prepared from 
lymph nodes of infected and uninfected mice 7 d after infection. 
Lymph node cells were prepared by homogenizing the lymph nodes 
in a loose fitting glass homogenizer and washing twice in PBS to 
remove fibrous debris.  1.6-1.8  x  107 sensitized  cells or 2  x  107 
unsensitized cells were injected intraperitoneally into naive mice 
with or without 50 #g purified protein derivative  (PPD) (kindly 
prepared by F. Romain, Pasteur Institute). Peritoneal cells were col- 
lected from these mice 48 h later, counted and cytospun onto poly- 
l-lysine coated slides. 
Other Treatments.  Nonlethal Plasmodium yoelii infection was es- 
tablished by injecting 100 #1 of infected mouse blood (stored at 
-70~  into the peritoneal cavity of mice (10). Sheep erythrocytes 
were injected intravenously in a volume of 100 #1. Resident, LPS 
and thioglycollate elicited peritoneal M~ were obtained by sterile 
peritoneal lavage from untreated animals or 4 d after intraperitoneal 
injection of 25 #g of LPS or 1 ml of thioglycollate broth. 
Tissue Processing.  Mice were killed with  CO2  and  perfused 
with 10 ml of heparinized PBS (50 U/ml) followed by 50 ml of 
4% paraformaldehyde in PBS. Small blocks of tissue were dissected 
and either fixed in 4% paraformaldehyde in PBS or immediately 
frozen in  liquid  nitrogen  in  OCT  embedding medium  (Miles 
Scientific, Naperville, IL). Tissue placed in paraformaldehyde was 
subsequently transferred to a sterile solution of 0.5 M sucrose in 
PBS and left overnight at 4~  before freezing in OCT. Tissue sec- 
tions of 5-10 #m were cut onto poly-blysine coated microscope 
slides. Isolated cells were cytospun onto poly-l-lysine coated slides 
and fixed and processed  as for the tissues. 
In Situ Hybridization.  Sections or cell preparations were fixed 
in 4% paraformaldehyde in PBS for 20 min at room temperature, 
washed three times in PBS, then dehydrated through graded eth- 
anol solutions and stored at  -20~  for up to 2 mo. 
Slides for in situ hybridization were processed by a modification 
of the method of Hogan et al. (11). Sections  were rehydrated in 
distilled water, treated with 0.2 M HC1 for 20 min, rinsed with 
10 mM "Iris, 1 mM EDTA buffer then treated with 20 #g/ml Pro- 
teinase  K in the same buffer for 10 min. Proteinase K digestion 
was stopped by incubating the slides with 0.2% (w/v) glycine in 
water for 30 s. Following this the slides were post-fixed  in 4% 
paraformaldehyde in PBS for 20 rain, washed three times in PBS 
then dehydrated through graded ethanol baths and air-dried for 
approximately I h. All steps were carried out at room temperature. 
Hybridization mixture with  105 cpm/#l of 35S-labeled RNA 
probe was pipetted onto dry slides and covered with clean siliconized 
glass coverslips. The hybridization mixture consisted of 50% for- 
mamide, 10% dextran sulphate,  0.01% BSA, 0.01% Ficoll 4000, 
0.01% polyvinylpyrollidone, 1 #g/#l tRNA, 10 mM Tris-HC1 pH 
7.4, 1 mM EDTA, 1 mM pyrophosphate, 10 mM dithiothreitol. 
Hybridization was carried out for 12 to 24 h at 37~  in a 50% 
formamide/H~O saturated environment. 
After hybridization, coverslips were removed by incubating the 
slides in a solution with the same composition as the hybridization 
mixture, but without dextran sulphate,  tKNA,  or radiolabeled 
probe, at 37~  for 1 to 2 h. The slides were washed in 0.5 M NaC1, 
10 mM Tris-HC1 pH 7.4, 1 mM EDTA (NTE buffer) for 15 rain 
then digested with 20 #g/ml RNAse A in NTE buffer for 30 min 
at 37~  The slides were rinsed once with NTE buffer then trans- 
ferred to 2xSSC (20xSSC  =  3 M NaC1, 0.3 M tri-sodium citrate) 
at 37~  for 1 h followed by 0.2xSSC at 45~  for another hour. 
Mouse lysozyme mKNA was detected by cross-species hybridiza- 
tion at low stringency; for TNF mRNA the hybridization and first 
wash were carried out at 50~  and the final SSC washes at 45~ 
(2xSSC) and 50~  (0.2xSSC).  After these washes the slides were 
dehydrated through graded ethanol baths containing 0.3 M NH4- 
Acetate,  air-dried and processed  for autoradiography. 
Radio-labeled Probes.  The 640 bp long BamHI/RsaI restriction 
fragment of the human lysozyme cDNA was subcloned in both 
directions into the HinclI site of the pGEM3 expression  vector 
plasmid  (Pharmacia,  Uppsala,  Sweden)  (4).  The  330 bp  long 
SacI/XbaI fragment of the murine TNF cDNA was subcloned into 
the multiple cloning site of the pT7T3 vector (Pharmacia)  (12). 
35S-labeled lysozyme RNA probes were prepared using T7 poly- 
merase on HindlII linearized plasmid templates,  and TNF KNA 
probes were prepared using T7 and T3 polymerase on HindlII and 
EcoKI linearized plasmid templates.  3zP-labeled DNA probes for 
Northern blots were prepared by the random oligonucleotide primer 
method (13). The BamHl/Ddel fragment of the human lysozyme 
cDNA and XbaI/SacI fragment of the murine TNF cDNA were 
used (4,  12). 
Dipping andAutoradiography.  Dried hybridized slides were dipped 
in Ilford K5 emulsion and exposed in the dark at 4~  for 3 to 
6 d. Autoradiographs were developed for 5 rain in Kodak D19 de- 
veloper at 17~  and counter-stained with Mayer's  haematoxylin 
or haematoxylin and eosin. 
Northern Blotting.  KNA was prepared from whole cells and snap- 
frozen organs after the method of Chirgwin et al. (14). Agarose- 
formaldehyde gels were run and processed by standard methods. 
Nitrocellulose  filters  were  hybridized  to  3zp-labeled probes  at 
42~  and washed at a final stringency of 0.1x SSC at 60~  (15). 
Results 
Lysozyme Expression In Situ In Normal Tissues.  We exam- 
ined a variety of tissues from normal adult and neonatal mice 
by in situ hybridization to establish the extent of lysozyme 
gene  expression  in  tissue  McI,  defined  previously by  im- 
munochemical localization of F4/80 antigen (16). Unlike al- 
veolar Mff', the majority of tissue McI, did not contain de- 
1050  Lysozyme  and Macrophage Activation In Situ Figure 1.  Lysozyme mRNA is constitutively expressed in vivo only in suhpopulations of tissue M~. A, B, C, E, & F were hybridized to the sss- 
labeled antisense  lysozyme RNA probe. D  was hybridized to the aSS-labeled sense strand (control) lysozyme KNA probe. A  and B show the same 
section of normal adult spleen, viewed by bright-field (A) and dark-field (B). The outline of the marginal zone is shown by the broken line, and some 
scattered lysozyme-positive  cells in the red pulp are indicated by the arrows.  C  shows a section of neonatal thymus hybridized to the lysozyme probe. 
Cortex and medulla are indicated by c and m, and arrows indicate lysozyme-positive  cells in the border region between cortex and medulla. D  shows 
a similar section of thymus hybridized to the control probe, indicating cortex (c) and medulla (m). A section of normal adult liver hybridized to the 
lysozyme probe is shown in E. An asterisk marks the lumen of a portal vein tributary, small arrows indicate two endothelial cells, and large arrows 
mark two Kupffer cells lining the hepatic sinusoids.  None of the cells indicated show any specific hybridization over the background level. F  shows 
a cytospin preparation of normal peripheral blood leukocytes,  prepared by dextran sedimentation and hypotonic lysis of erythrocytes, hybridized to 
the antisense lysozyme probe. Multilobed and ring-form neutrophil nuclei are seen, and indented monocyte nuclei are indicated by arrows. No detectable 
lysozyme signal is associated with cells in the field. Autoradiographs were exposed for 6 to 8 d, and counterstained with hematoxylin and eosin (A-E) 
or hematoxylin (F). tectable lysozyme mRNA (4). Low levels were found in the 
red pulp of the spleen (Fig.  1 A  and B), scattered positive 
cells were found in the cortico-medullary region of the neo- 
natal thymus (Fig. 1 C) and a few positive cells were found 
in the subcapsular area of mesenteric lymph nodes. The dis- 
tribution of these cells was compatible with their being McI,, 
but the majority of F4/80 + cells were negative. 
Prominent M~ populations such as Kupffer cells of the 
liver, lamina propria Mq' in the intestine, microglia in the 
brain and resident M~ in the leptomeninges  and choroid plexus 
were uniformly negative (Fig. 1 E). Peripheral blood mono- 
cytes and neutrophils were generally lysozyme mRNA nega- 
tive, with only occasional cells showing weak hybridization 
(Fig. 1 E). Apart from strongly positive Paneth cells in the 
small intestine (4), no lysozyme producing epithelial cells were 
detected in the gastrointestinal tract, male urogenital tract, 
kidney or resting, gestating or lactating female genital tract 
and breast.  F4/80 + cells in these organs also lacked lyso- 
zyme mRNA. No other cell types, including tear gland and 
salivary gland cells, were lysozyme-positive. Although human 
tears and saliva are lysozyme-rich, mouse saliva collected after 
pilocarpine stimulation had a much lower concentration of 
lysozyme activity, while mouse tears contained no detectable 
activity (not shown). 
Bacille Calmette Guerin (BCG) Infection Induces Lysozyme 
Extrression in Macrophages  (M~) In Viva  BCG infection results 
in the recruitment of large numbers of immunologically ac- 
tivated M6 to granulomas in the organs of infected mice (7, 
8). We therefore infected mice with live BCG organisms and 
examined the liver and spleen by in situ hybridization for 
lysozyme mKNA. As shown in Fig. 2 A, lysozyme-positive 
cells appeared in the marginal zone of the spleen within I d 
of intravenous infection. By day 7 of the infection, the signal 
in the spleen was greatly increased but was still localized mainly 
to the marginal zone, with some positive cells also appearing 
in the white pulp (Fig. 2, C and D). The intensity and extent 
of labeling increased further during the course of infection 
and in addition to strong labeling of marginal zone cells, foci 
of labeled cells were found in the red and white pulp. By 
21 d of infection the architecture of the spleen was disrupted 
and  collections  of  lysozyme-positive  cells  were  found 
throughout the organ (Fig.  2, E  and F).  Control sections 
hybridized to the sense strand probe showed no specific signal. 
Lysozyme-positive granulomas in the liver developed more 
slowly. Unlike the spleen,  there was no induction of lyso- 
zyme mP,  NA 24 h after infection. The majority of cells in 
the granulomas which eventually develop are F4/80 + MO 
(S. Rabinowitz, unpublished observations),  so the extent of 
labeling of lysozyme-positive cells is consistent with their 
being MO (Fig. 3 A). Although a few sinusoidal cells, which 
may be Kupffer cells or migrating monocytes, were labeled, 
the majority of Kupffer cells were lysozyme-negative even 
in infected animals (Fig. 3 B). Further studies examined the 
role of T  cells in the induction of lysozyme expression  in 
situ.  BCG infection in congenitally athymic (nude) mice 
resulted in small foci of lysozyme-positive cells appearing in 
the liver and spleen. The number and size of granulomas was 
less than in euthymic littermates, but the intensity of the lyso- 
zyme signal in M~ was comparable (not shown). 
To examine the effect of specific antigen challenge,  PPD 
was injected intraperitoneally into BCG infected mice and 
lysozyme mRNA levels in peritoneal cells determined by in 
situ hybridization to cytospin preparations of cells recovered 
24 h later. The combination of infection and antigen chal- 
lenge yielded strongly lysozyme-positive M~ which were 
shown in separate cytospin preparations to be F4/80 + and 
MHC dass II +. Peritoneal cells from infected mice without 
PPD challenge or uninfected mice with PPD challenge were 
weakly positive. In adoptive transfer experiments, sensitized 
lymphocytes and PPD injected together into the peritoneal 
cavity of naive mice yielded a population of peritoneal cells 
with increased lysozyme expression  (data  not shown). 
Modulation of  Lysozyme Gene Expression  In Macrophages  (M~) 
by Other Stimuli.  In view of the localized and rapid appear- 
ance of the lysozyme-positive cells in the spleen after BCG 
infection, we examined the effect of another infectious agent, 
P. yoelii, which is also known to activate M~ function in 
the spleen and liver (10). Fig. 4 shows that marked induction 
of lysozyme gene expression is seen in the marginal zone of 
the spleen within 1 d of intraperitoneal injection of P. yoelii 
parasitized  mouse erythrocytes (Fig. 4 A). In the course of 
the following 21 d, lysozyme-positive cells were concentrated 
in the white pulp, and red pulp labeling was less evident than 
in the case of BCG infection. Scattered lysozyme-positive cells 
were also seen in the liver, but these were only a proportion 
of the heavily pigment-laden phagocyte population. To ex- 
plore the early induction of lysozyme mRNA in marginal 
zone M~, sheep erythrocytes were injected intravenously into 
normal mice. This too resulted in the rapid appearance  of 
lysozyme-positive cells in the marginal zone (Fig. 4 B). Un- 
like the injection of live infectious agents, however, injection 
of sheep erythrocytes generated a short-lived effect which dis- 
appeared  within 7 d. 
Regulation of Lysozyme Expression In Vivo Is Distinct  from 
that of Tumor Necrosis Factor  (TNF).  Since lysozyme expres- 
sion was inducible rather than constitutive in most M~ in 
vivo, it was of interest to compare its induction with that 
of a induced inflammatory product such as TNF (17). It is 
well known that TNF mRNA and protein expression  are 
increased in vitro in Mq~ which have been treated with LPS. 
In addition, it has been shown that TNF is present in granu- 
loma M~ in vivo, and that the production of TNF is essen- 
tial for granuloma formation in response to BCG infection 
(9). In Fig. 5, we demonstrate the presence of TNF mRNA 
in granuloma cells by in situ hybridization to the routine TNF 
probe. In contrast to lysozyme mRNA, which was uniformly 
distributed among the granuloma cells, only a proportion 
of M~ in the granuloma contained TNF mP,  NA (Fig. 3 and 
5). Furthermore, when BCG infected mice were injected with 
LPS, TNF mRNA expression was massively induced in granu- 
loma cells as well as in other cells in the hepatic sinusoids. 
Lysozyme mRNA levels, in contrast, were not enhanced by 
LPS treatment. This was confirmed by Northern blot anal- 
ysis, which showed clear elevation of TNF mP,  NA levels by 
1052  Lysozyme  and Macrophage Activation In Situ Figure 2.  Lysozyme mtLNA is progressively induced in MO subpopulations in BCG infected spleen. All sections were hybridized to the antisense 
3sS-labeled lysozyme probe. The left hand photographs show bright field views and the right hand photographs show the corresponding dark-field 
illumination view. Arrows indicate the position of the marginal zone.  (.,4 and B) Spleen from an animal injected 24 h previously with 107 BCG or- 
ganisms.  There is a ring of positive cells in the marginal zone (arrows), which is more marked than that in the normal spleen (Fig.  1 A  and B).  (C 
and D) 7 d after infection the number of positive cells and strength of the signal is increased. The signal is still largely confined to the marginal zone 
and the interior of the white pulp (arrows). (E and F) 21 d after infection lysozyme-positive  cells are scattered throughout the spleen in small granuloma- 
like foal.  Autoradiographs were exposed for 6 to 8 d and counterstained with hematoxylin and eosin. 
1053  Keshav et al. Figure  3.  Lysozyme  mRNA  is  expressed  in 
granuloma M~ and sinusoidal  cells in BCG in- 
fected liver. Liver sections from BCG infected mice 
21 d after BCG infection hybridized to the antisense 
3sS-labeled  lysozyme probe. A  shows a low power 
view of the liver, with lysozyme-positive granu- 
lomas scattered through the pareuchyma (aster/sks). 
A  few isolated, lysozyme-positive cells may also 
be seen (arrows). At higher magnification (B), it 
can be seen that the lysozyme signal is distributed 
evenly, and is present in the majority of granu- 
loma cells (asterisk). A few lysozyme-positive  cells 
are also seen in the sinusoids (arrows). At the same 
time  large  adherent  sinusoidal  cells  (probably 
Kupffer cells) indicated by solid arrowheads,  are 
negative,  as are the endothelial cells  (flattened, 
darkly stained nuclei, indicated by open  arrowheads). 
Autoradiographs were exposed for 6 d and coun- 
terstained with haematoxylin and eosin. 
BCG infection and further induction of expression in liver, 
lung and intestine by subsequent LPS challenge (Fig. 6). In 
the lung, TNF and lysozyme mRNA are detectable in the 
normal state, although the TNF signal is much less than the 
lysozyme signal,  and both are increased by infection. The 
hybridization signals in these organs are presumed to arise 
from McI). In the small intestine there is a clearly detectable 
lysozyme signal  (derived  from Paneth cells) in the normal 
state,  while the TNF signal is much weaker. 
Discussion 
The wide dispersion and diverse phenotype of tissue M~ 
suggest an active role for these cells in tissue homeostasis and 
defense. To study the secretory activity of tissue McI  ' in vivo 
more closely, lysozyme was chosen as a well characterized 
indicator of M~ secretory potential. Earlier studies had indi- 
cated that lysozyme production was restricted to only a few 
cell types and that lysozyme production by M~ in vitro was 
a  constitutive function which  could potentially label  all 
differentiated  Mr  TNF, an inflammatory cytokine which 
is also produced almost exclusively by M~I', but is dependent 
on activation for full expression,  was  studied in parallel. 
We noted previously that lysozyme mRNA was produced 
constitutively by M~ in tissue culture, but that the majority 
of tissue M~ did not transcribe the gene in vivo in the resting 
animal (4). The more extensive survey reported here confirms 
this generalization. In addition, it seems that lysozyme produc- 
tion in the steady state is correlated with phagocytic activity, 
either of foreign material (as in alveolar M~I' of the lung) 
or of endogenous ligands (as in M~ of the neonatal thymus 
and red pulp of the spleen). Furthermore, a number of the 
1054  Lysozyme and Macrophage Activation In Situ Figure 4.  Plasmodium  yoelii infection and sheep erythrocytes rapidly in- 
duce lysozyme mR.NA expression in marginal zone M~ of the spleen. 
Sections of murine spleen, 24 h after injection of P. yoelii infected erythro- 
cytes (A) or normal sheep erythrocytes (/3) were hybridized to the 3sS- 
labeled antisense lysozyme probe. A  shows a bright field view, while B 
is dark field view to enhance the autoradiographic signal. The area of the 
marginal zone is indicated by arrows. Strongly positive cells are seen in 
the marginal zone in both sections, while a few positive cells also appear 
to be present in the white pulp itself in B. This is probably caused by 
oblique sectioning of a nodule of white pulp. Autoradiographs were ex- 
posed for 8 d, and stained with haematoxylin. 
lysozyme-positive M~ populations lack F4/80 antigen, but 
do express other Mob antigens such as SEtL and FA-11 (refer- 
ence 18;  S.  Rabinowitz, unpublished observations). 
Most epithelial cells were likewise negative for lysozyme 
mRNA, even in organs where lysozyme is secreted (for ex- 
ample in the salivary gland). This may be due to limitations 
in the sensitivity of in situ hybridization and Northern blot 
techniques, and low levels of lysozyme, distributed relatively 
uniformly among many cells, may in fact be produced in some 
of the tissues which appear negative. Nevertheless,  some of 
the negative results are noteworthy. The absence of detect- 
able lysozyme mRNA in kidney contrasts strongly with the 
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abundance of the protein in cells of the proximal convoluted 
tubule, and demonstrates a potential source of experimental 
error where proteins produced in one site are sequestered in 
another. The same phenomenon may occur when paracrine 
secretions are localized immunochemically  on the target cell 
rather than the source. 
In Kupffer cells, which do not contain detectable quanti- 
ties of lysozyme mRNA, the absence of lysozyme biosyn- 
thesis may reflect a more general refractory state (19). How- 
ever BCG infection followed by LPS injection may be sufficient 
to induce TNF production in some of these cells (Fig. 5 B). 
Although the present data indicate that newly recruited Mob 
constitute the major lysozyme expressing population, fur- 
ther experiments are required to  distinguish resident  and 
recruited cells definitively. 
In  infected animals,  lysozyme mRNA  production was 
strongly induced compared to normal controls. Lysozyme 
production was, however, confined to discrete subpopulations 
of Mq~, while the majority of tissue Mq~ remained lysozyme- 
negative. In the spleen,  for example, lysozyme gene activa- 
tion in the early stages of infection was confined to the mar- 
ginal zone, the area where blood-borne thymus independent 
carbohydrate antigens are initially trapped and engulfed by 
M~ (20-22).  The marginal zone is also the site of entry of 
peripheral blood monocytes into the spleen, so that the lyso- 
zyme signal may result from newly recruited cells stimulated 
in the circulation. The persistence  of the signal,  and its ex- 
tension into the red and white pulp with continuing infec- 
tion, suggest that the lysozyme-positive cells remain local- 
ized even if they are initially stimulated in the circulation. 
In BCG-infected liver, while the majority of Kupffer  cells 
lacked lysozyme mRNA, some monocytes in the sinusoids 
were lysozyme-positive, and these and other cells presum- 
ably contribute to the formation of granulomas in which the 
lysozyme gene is persistently transcribed. 
The observation that sheep erythrocytes and P. yoelii in- 
fected mouse erythrocytes also induced lysozyme gene ex- 
pression in the marginal zone suggests that lysozyme gene 
expression by M~ is associated with active phagocytosis. Plas- 
modium and BCG induced lysozyme gene expression was 
prolonged, while sheep erythrocyte induced expression was 
relatively transient, possibly reflecting the persistence of the 
initiating stimulus. 
Activation of M~ in vitro for full bactericidal  function 
requires  the participation of T  cells, and many nonspecific 
inflammatory stimuli produce only a partially activated pheno- 
type (23). The effects  of BCG infection in congenitally athymic 
mice indicate that lysozyme gene expression in Mob can be 
induced independent of mature T cell function. At the same 
time it is evident that T cell products may increase M~ lyso- 
zyme production in peritoneal cells from BCG primed animals 
challenged with an intraperitoneal dose of PPD. 
Although lysozyme gene expression in Mq~ is inducible 
in vivo, the regulation of lysozyme expression remains dis- 
tinct from that of an inflammatory cytokine such as TNF. 
Lysozyme,  which is completely nontoxic to the host, and 
acts as a nonspecific antibacterial defense, is produced rapidly 
and continuously in response to many stimuli. TNF, on the Figure 5.  TNF mKNA is expressed  in BCG 
granulomas, and further induced by LPS injection. 
A  and B show sections of mouse liver 16 d after 
infection with BCG, hybridized to the antisense 
3sS-labded  TNF  probe.  In A,  the  granulomas 
(amaos) show moderate hbeling of most cells, while 
one  granuloma  (bottom  right  corner)  is  more 
strongly labeled.  Kupffer cells seem to be TNF- 
negative.  In B, after injection with LPS, the in- 
tensity of the signal, and the number of TNF- 
positive cells is greatly  increased. In the granulomas 
(solid arrows), the TNF signal is increased in in- 
dividual cells, and is also greatest in cells on the 
periphery of the granuloma.  In addition, TNF 
mRNA is induced in cells outside the granulomas 
(open arrows). Autoradiographs were exposed for 
6 d, and stained with haematoxylin and eosin. 
other hand, which has complex physiological  effects,  including 
definite host toxicity, is tightly regulated. Furthermore, while 
lysozyme secretion is decreased in vitro by LPS treatment, 
and unchanged in vivo, TNF production is markedly  induced 
by LPS treatment (24, 25). Lysozyme gene expression is not 
regulated posttranscriptionally, while TNF production is regu- 
lated by changes in mRNA stability and translation rate (25). 
As this can result in the localization of mRNA in cells which 
are not actually producing the relevant protein, a complete 
description  of in situ secretory activity for proteins  such as 
TNF requires localization ofmRNA and protein. As regula- 
tory elements of the TNF gene have been recently described, 
and both mouse and human lysozyme genes cloned, it will 
be possible to compare lysozyme and TNF gene regulation 
at the molecular level (26-28).  Additional information re- 
garding tissue-specific gene regulation may also be obtained 
by comparing the two mouse lysozyme genes (6). 
While cell lines derived from colon carcinomas and hepa- 
tomas can produce lysozyme, only myelomonocytic  cells and 
specialized exocrine cells (such as Paneth cells) produce lyso- 
zyme in vivo (29, 30). Lysozyme production could therefore 
be useful as a marker of myelomonocytic  cell activity in dis- 
ease. Furthermore, as neutrophils contain mainly preformed 
lysozyme in their granules while mature M~ retain the ability 
to synthesize new protein, lysozyme mRNA levels in vivo 
specifically monitor changes in M~ biosynthetic and secre- 
tory activity induced  by phagocytic and T cell derived stimuli. 
1056  Lysozyme  and Macrophage Activation In Situ Figure 6.  Superinduction of TNF but not lysozyme  mRNA by LPS. Northern blot showing hybridization of 3zp-labded TNF and lysozyme  probes 
to RNA from gut (G), lung (Lu) and liver (Li) of normal mice, mice infected with BCG 21 d earlier, and mice infected with BCG and challenged 
with 25/zg of LPS for 2 h. Each lane was loaded with 20 gg of total RNA, and ethidium bromide staining used to assess the position of ribosomal 
RNA bands (28s and 18s) and to ensure even loading. The predominant TNF mRNA band migrates at about 1.7 kb, and the lysozyme mRNA band 
at about 1.3 kb. Autoradiograms were exposed for 24 h before development. 
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